(Q53873000)

English

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

scientific article published in January 2005

In more languages

edit

Statements

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

title

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

11

Giovanni Scambia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

author name string

Simona Mozzetti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Cristiano Ferlini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Flavia Filippetti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Giuseppina Raspaglio

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Silvia Prislei

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Daniela Gallo

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Enrica Martinelli

series ordinal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Franco Oreste Ranelletti

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Gabriella Ferrandina

series ordinal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

page(s)

298-305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 January 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15671559%20AND%20SRC:MED&resulttype=core&format=json

(Q53873000)

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)